What patent covers Soltamox (tamoxifen citrate) and who holds it?
“Soltamox” is a brand name for tamoxifen citrate, a medicine used in breast cancer. The question of “the Soltamox patent” depends on the specific jurisdiction (country) and the exact patent family: patents can cover different things such as the original active ingredient, formulation, manufacturing process, packaging, or method-of-use claims. With only the phrase “Soltamox patent” provided, there isn’t enough information to identify a single patent number or owner unambiguously.
When does the Soltamox (tamoxifen) patent expire?
Patent expiry timing depends on the specific patent (and the country). Even within one medicine name like Soltamox, different patents can expire at different times because each patent has its own term and may have multiple continuations or related patents in the same family. Without the relevant country and patent number (or a link to the product monograph/label), the exact expiry date can’t be stated accurately.
Can generic or biosimilar Soltamox enter before patent expiry?
For tamoxifen (a small-molecule drug), the relevant pathway is typically generic competition rather than biosimilars. Generics can sometimes launch before the latest patent in a family if earlier patents covering the reference product expire or if a regulatory process allows it. Whether that is possible depends on the specific patents listed for the reference product in that jurisdiction.
What does “Soltamox patent” search results usually refer to?
People searching “Soltamox patent” often mean one of these:
- the first patent that protected tamoxifen’s initial development
- later “evergreening” patents (for example, specific formulations or manufacturing improvements)
- regulatory patent lists (in some countries, medicines have patents listed for reference against generic entry)
- patent litigation tied to generic launches
Which details do I need to give the exact Soltamox patent number and expiry date?
If you share any one of the following, I can narrow it to the exact patent(s) and timelines:
- the country (e.g., US, UK, Canada, EU)
- a patent number you saw mentioned
- a link to the listing or article you’re referencing
- whether you mean the brand product (Soltamox) or the active ingredient (tamoxifen)
If you’re looking for the “key patent” for Soltamox, tell me your jurisdiction
Reply with the country (or the link/patent number you saw), and I’ll identify the relevant patent family and the likely expiry/termination windows based on the specific claims those patents cover.